TokenPost·
PTC Therapeutics Raises 2026 Product Revenue Outlook, Now $960 Million to $990 Million
The company also projects total revenue of $1.29 billion to $1.32 billion and expects cash flow breakeven in 2026.
More news
- The DefiantBinance Expects to Start Resuming Withdrawals Within 48 Hours
- TokenPostKraken Acknowledges Connection and Order Problems Across Its Services
- TokenPostOndo Finance (ONDO) Jumps 7.62% in Four Hours to $0.3899
- TokenPostUniswap Rises 6.94% in Four Hours to $6.75 on Binance
- TokenPostSui Rises 7.02% in Four Hours to $0.8891 as Short Liquidations Reach $60,000
- TokenPostAvalanche (AVAX) Gains 5.82% in Four Hours to Reach $8.49